Liraglutide, a Long-Acting Human Glucagon-Like Peptide 1 Analog, Improves Glucose Homeostasis in Marginal Mass Islet Transplantation in Mice-Reference-Cited by-同舟云学术

Liraglutide, a Long-Acting Human Glucagon-Like Peptide 1 Analog, Improves Glucose Homeostasis in Marginal Mass Islet Transplantation in Mice

Published:2008-05-29 Issue:9 Volume:149 Page:4322-4328
ISSN:0013-7227
Container-title:Endocrinology
language:en
Short-container-title:

Author:

Merani S.¹,Truong W.¹,Emamaullee J. A.¹,Toso C.¹,Knudsen L. B.²,Shapiro A. M. J.¹³

Affiliation:

1. Surgical Medical Research Institute (S.M., W.T., J.A.E., C.T., A.M.J.S.), Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada T6G 2C8

2. Novo Nordisk (L.B.K.), BK-2880 Bagsvaerd, Denmark

3. Clinical Islet Transplant Program (A.M.J.S.), University of Alberta, Edmonton, Canada T6G 2C8

Publisher

The Endocrine Society

Subject

Endocrinology

Link

http://academic.oup.com/endo/article-pdf/149/9/4322/8999135/endo4322.pdf

Reference34 articles.

1. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.;Shapiro;N Engl J Med,2000

2. Five-year follow-up after clinical islet transplantation.;Ryan;Diabetes,2005

3. International trial of the Edmonton protocol for islet transplantation.;Shapiro;N Engl J Med,2006

4. Beneficial metabolic impact of the novel immunosuppressant rapamycin in chronic canine islet autograft recipients.;Kneteman;Transplant Proc,1995

5. The efficacy and toxicity of rapamycin in murine islet transplantation. In vitro and in vivo studies.;Fabian;Transplantation,1993

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liraglutide Protects Pancreatic Islet From Ischemic Injury by Reducing Oxidative Stress and Activating Akt Signaling During Cold Preservation to Improve Islet Transplantation Outcomes;Transplantation;2024-04-05

2. The potential of cellular transplantation to harness autoimmunity and reverse clinical diabetes;Translational Autoimmunity;2023

3. 14-3-3-zeta mediates GLP-1 receptor agonist action to alter α cell proglucagon processing;Science Advances;2022-07-22

4. Inducible Pluripotent Stem Cells as a Potential Cure for Diabetes;Cells;2021-01-30

5. Implanted islet mass influences the effects of dipeptidyl peptidase-IV inhibitor LAF237 on transplantation outcomes in diabetic mice;Biomedical Journal;2020-10